Adipotide

Adipotide

Adipotide is a research-use-only peptide based on a modified form of the adipocyte-targeting protein derived from the Bombyx mori silk gland protein. This peptide is being investigated in preclinical studies for its potential to selectively bind to adipose tissue, primarily targeting adipocytes (fat cells) through the fatty acid transport protein 2 (FATP2). Due to its highly specific cellular binding, adipotide holds promise for applications in basic biological research, including studies on metabolic processes, tissue engineering, and pharmaceutical drug delivery systems.

Research Context

Adipotide was initially developed for its potential to serve as a molecular probe for studying adipose tissue biology. In preclinical models, it has demonstrated selective accumulation in adipocytes while exhibiting minimal off-target effects in other cell types. This specificity makes it valuable for researchers studying adipocyte metabolism, obesity research, and the development of targeted therapeutic interventions. The peptide’s structure enables it to cross biological membranes and bind to fatty acid receptors, facilitating studies of lipid metabolism, inflammation, and energy homeostasis.

Research Overview

Preclinical investigations involving adipotide have primarily focused on its role as a tracer molecule for imaging studies and as a tool for modulating adipocyte function. Studies in rodents have shown that adipotide can be administered systemically and reliably localize to adipose depots, enabling researchers to visualize and analyze fat tissue distribution in vivo. Additionally, its potential applications in drug delivery systems, particularly for lipophilic compounds, remain under investigation. Research teams are exploring how adipotide could enhance the precision of targeted therapies in metabolic disorders, though further validation is required before translational applications can be pursued.

Key Research Focus Areas

• Adipocyte-specific labeling: Utilizing adipotide for high-contrast imaging of fat tissues in preclinical models to study metabolic dynamics.
• Basic molecular biology: Investigating the peptide’s interaction with FATP2 and other adipocyte-associated receptors to elucidate mechanisms of fat cell regulation.
• Drug delivery systems: Exploring the use of adipotide as a carrier for lipophilic pharmaceutical agents in targeted adipose tissue delivery.
• Obesity and metabolic research: Evaluating the peptide’s potential role in studies of obesity, insulin resistance, and adipose tissue remodeling.
• Tissue engineering: Investigating adipotide’s use in scaffold formulations for adipose tissue regeneration or reconstruction studies.

Safety and Compliance Note

Adipotide is provided for research purposes only and is not intended for human or animal consumption. Research institutions must adhere to all applicable regulatory guidelines, including proper handling protocols, disposal procedures, and institutional review board (IRB) or ethics committee approvals when conducting experiments involving this material. Users are responsible for ensuring compliance with local, national, and international laws governing the use of peptides in biological research. This product is not authorized for any therapeutic, diagnostic, or cosmetic applications.

For research use only. Not for human or animal consumption.